A. John Iafrate

A. John Iafrate is a prominent academic figure at Harvard University, where they contribute to the Pathology through intensive research in cancer genomics, molecular diagnostics, lung cancer, colorectal cancer, precision oncology, tumor mutations, therapeutic biomarkers, cancer pathology. John Iafrate's influence spans a wide range of high-impact publications. A representative example of their recent contribution is the study titled "The NCI-MATCH trial: lessons for precision oncology", which offers critical insights into the dynamics of cancer genomics and molecular diagnostics. Additional work such as "T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19" further demonstrates their commitment to advancing knowledge in this domain.